• 3279 Citations
  • 29 h-Index
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3279 Citations
  • 29 h-Index
  • 146 Article
  • 9 Review article
  • 1 Comment/debate
Filter
Article
2020

Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer

Son, K. L., Jung, D., Lee, K. M., Hwang, H., Lee, J. Y., Kim, T. Y., Im, S. A., Lee, K. H., Spiegel, D. & Hahm, B. J., 1 Mar 2020, In : Supportive Care in Cancer. 28, 3, p. 1351-1358 8 p.

Research output: Contribution to journalArticle

The effect of perceived social support on chemotherapy-related symptoms in patients with breast cancer: A prospective observational study

Oh, G. H., Yeom, C. W., Shim, E. J., Jung, D., Lee, K. M., Son, K. L., Kim, W. H., Moon, J. Y., Jung, S., Kim, T. Y., Im, S. A., Lee, K. H. & Hahm, B. J., Mar 2020, In : Journal of Psychosomatic Research. 130, p. 109911 109911.

Research output: Contribution to journalArticle

TDP1 and TOP1 modulation in Olaparib-resistant cancer determines the efficacy of subsequent chemotherapy

Kim, J. W., Min, A., Im, S. A., Jang, H., Kim, Y. J., Kim, H. J., Lee, K. H., Kim, T. Y., Lee, K. W., Oh, D. Y., Kim, J. H. & Bang, Y. J., 3 Feb 2020, In : Cancers. 12, 2, 334.

Research output: Contribution to journalArticle

Open Access

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study

Bang, Y. J., Li, C. P., Lee, K. H., Chiu, C. F., Park, J. O., Shan, Y. S., Kim, J. S., Chen, J. S., Shim, H. J., Rau, K. M., Choi, H. J., Oh, D. Y., Belanger, B. & Chen, L. T., 1 Feb 2020, In : Cancer Science. 111, 2, p. 513-527 15 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

A One-Bag Rapid Desensitization Protocol for Paclitaxel Hypersensitivity: A Noninferior Alternative to a Multi-Bag Rapid Desensitization Protocol

Lee, J. H., Moon, M., Kim, Y. C., Chung, S. J., Oh, J., Kang, D. Y., Lee, S. Y., Lee, K. H., Yun, J. & Kang, H. R., Feb 2020, In : Journal of Allergy and Clinical Immunology: In Practice. 8, 2, p. 696-703 8 p.

Research output: Contribution to journalArticle

2019

Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response

Jeon, S. H., Chie, E. K., Kim, Y. J., Lee, K. H., Lee, H. S., Kim, M. J., Im, S. A., Kim, J. I. & Kim, T. Y., 2 Dec 2019, In : International Journal of Radiation Biology. 95, 12, p. 1640-1647 8 p.

Research output: Contribution to journalArticle

Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer

Choi, M., Han, J., Yang, B. R., Jang, M. J., Kim, M., Kim, T. Y., Im, S. A., Lee, H. B., Moon, H. G., Han, W., Noh, D. Y. & Lee, K. H., 1 Dec 2019, In : Oncologist. 24, 12, p. e1268-e1276

Research output: Contribution to journalArticle

Amenorrhea and menopause in patients with breast cancer after chemotherapy

Shin, J. J., Choi, Y. M., Jun, J. K., Lee, K. H., Kim, T. Y., Han, W. & Im, S. A., Dec 2019, In : Journal of Breast Cancer. 22, 4, p. 624-634 11 p.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Kim, T. Y., Han, H. S., Lee, K. W., Zang, D. Y., Rha, S. Y., Park, Y. I., Kim, J. S., Lee, K. H., Park, S. H., Song, E. K., Jung, S. A., Lee, N. M., Kim, Y. H., Cho, J. Y. & Bang, Y. J., 1 Nov 2019, In : Gastric Cancer. 22, 6, p. 1206-1214 9 p.

Research output: Contribution to journalArticle

2 Scopus citations
1 Scopus citations

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

Yoo, C., Im, H. S., Kim, K. P., Oh, D. Y., Lee, K. H., Chon, H. J., Kim, J. H., Kang, M., Kim, I., Lee, G. J., Oh, S. Y., Choi, Y., Choi, H. J., Kim, S. T., Park, J. O. & Ryoo, B. Y., 1 Aug 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
1 Scopus citations
2 Scopus citations

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

Kim, J. Y., Park, S., Im, S. A., Kim, S. B., Sohn, J., Lee, K. S., Chae, Y. S., Lee, K. H., Kim, J. H., Im, Y. H., Kim, T. Y., Lee, K. H., Ahn, J. H., Kim, G. M., Park, I. H., Lee, S. J., Han, H. S., Kim, S. H., Jung, K. H. & Park, Y. H., 28 May 2019, In : Cancer Communications. 39, 1, 29.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Pruritus in patients under targeted anticancer therapy: A multidimensional analysis using the 5-D itch scale

Cho, S. I., Lee, J., Lim, J., Park, J. S., Kim, M., Kim, T. Y., Kim, T. M., Lee, K. H., Keam, B., Han, S. W. & Jo, S. J., 1 Apr 2019, In : Acta Dermato-Venereologica. 99, 4, p. 435-441 7 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells

Lee, M., Lee, K. H., Min, A., Kim, J., Kim, S., Jang, H., Lim, J. M., Kim, S. H., Ha, D. H., Jeong, W. J., Suh, K. J., Yang, Y. W., Kim, T. Y., Oh, D. Y., Bang, Y. J. & Im, S. A., 1 Jan 2019, In : Cancer Research and Treatment. 51, 2, p. 451-463 13 p.

Research output: Contribution to journalArticle

4 Scopus citations

Phase I dose-finding study of OPB-111077, a novel STAT3 inhibitor, in patients with advanced hepatocellular carcinoma

Yoo, C., Kang, J., Lim, H. Y., Kim, J. H., Lee, M. A., Lee, K. H., Kim, T. Y. & Ryoo, B. Y., 1 Jan 2019, In : Cancer Research and Treatment. 51, 2, p. 510-518 9 p.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Randomized open label phase III trial of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane: Proceed trial (KCSG BR 11-01)

Park, I. H., Im, S. A., Jung, K. H., Sohn, J. H., Park, Y. H., Lee, K. S., Sim, S. H., Park, K. H., Kim, J. H., Nam, B. H., Kim, H. J., Kim, T. Y., Lee, K. H., Kim, S. B., Ahn, J. H., Lee, S. & Ro, J., 1 Jan 2019, In : Cancer Research and Treatment. 51, 1, p. 43-52 10 p.

Research output: Contribution to journalArticle

4 Scopus citations
2018

A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial

Park, Y. H., Lee, K. H., Sohn, J. H., Lee, K. S., Jung, K. H., Kim, J. H., Lee, K. H., Ahn, J. S., Kim, T. Y., Kim, G. M., Park, I. H., Kim, S. B., Kim, S. H., Han, H. S., Im, Y. H., Ahn, J. H., Kim, J. Y., Kang, J. & Im, S. A., 15 Dec 2018, In : International Journal of Cancer. 143, 12, p. 3240-3247 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response

Min, A., Jang, H., Kim, S., Lee, K. H., Kim, D. K., Suh, K. J., Yang, Y., Elvin, P., O'Connor, M. J. & Im, S. A., Dec 2018, In : Molecular cancer therapeutics. 17, 12, p. 2507-2518 12 p.

Research output: Contribution to journalArticle

4 Scopus citations

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial

Chen, L. T., Siveke, J. T., Wang-Gillam, A., Li, C. P., Bodoky, G., Dean, A. P., Shan, Y. S., Jameson, G. S., Macarulla, T., Lee, K. H., Cunningham, D., Blanc, J. F., Chiu, C. F., Schwartsmann, G., Braiteh, F. S., Mamlouk, K., Belanger, B., de Jong, F. A. & Hubner, R. A., Dec 2018, In : European Journal of Cancer. 105, p. 71-78 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity

Chung, S. J., Kang, S. Y., Kang, R. Y., Kim, Y. C., Lee, K. H., Kim, T. Y., Han, S. W. & Kang, H. R., 1 Nov 2018, In : Cancer Chemotherapy and Pharmacology. 82, 5, p. 777-785 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

The impact of skin problems on the quality of life in patients treated with anticancer agents: A cross-sectional study

Lee, J., Lim, J., Park, J. S., Kim, M., Kim, T. Y., Kim, T. M., Lee, K. H., Keam, B., Han, S. W., Mun, J. H., Cho, K. H. & Jo, S. J., 1 Oct 2018, In : Cancer Research and Treatment. 50, 4, p. 1186-1193 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: Patient-reported outcomes from the EMBRACA phase III trial

Ettl, J., Quek, R. G. W., Lee, K. H., Rugo, H. S., Hurvitz, S., Gonçalves, A., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., Roché, H., Im, Y. H., Markova, D., Bhattacharyya, H., Hannah, A. L., Eiermann, W., Blum, J. L. & Litton, J. K., 1 Sep 2018, In : Annals of Oncology. 29, 9, p. 1939-1947 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells

Min, A., Kim, J. E., Kim, Y. J., Lim, J. M., Kim, S., Kim, J. W., Lee, K. H., Kim, T. Y., Oh, D. Y., Bang, Y. J. & Im, S. A., 28 Aug 2018, In : Cancer Letters. 430, p. 123-132 10 p.

Research output: Contribution to journalArticle

5 Scopus citations

Talazoparib in patients with advanced breast cancer and a germline BRCA mutation

Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Gonçalves, A., Lee, K. H., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., Roché, H., Im, Y. H., Quek, R. G. W., Markova, D., Tudor, I. C., Hannah, A. L., Eiermann, W. & Blum, J. L., 23 Aug 2018, In : New England Journal of Medicine. 379, 8, p. 753-763 11 p.

Research output: Contribution to journalArticle

239 Scopus citations

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial

Jang, J. Y., Han, Y., Lee, H., Kim, S. W., Kwon, W., Lee, K. H., Oh, D. Y., Chie, E. K., Lee, J. M., Heo, J. S., Park, J. O., Lim, D. H., Kim, S. H., Park, S. J., Lee, W. J., Koh, Y. H., Park, J. S., Yoon, D. S., Lee, I. J. & Choi, S. H., 1 Aug 2018, In : Annals of Surgery. 268, 2, p. 215-222 8 p.

Research output: Contribution to journalArticle

85 Scopus citations

Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy

Cho, N., Im, S. A., Cheon, G. J., Park, I. A., Lee, K. H., Kim, T. Y., Kim, Y. S., Kwon, B. R., Lee, J. M., Suh, H. Y. & Suh, K. J., 1 Mar 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 3, p. 328-339 12 p.

Research output: Contribution to journalArticle

11 Scopus citations

Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

Park, Y. H., Im, S. A., Kim, S. B., Sohn, J. H., Lee, K. S., Chae, Y. S., Lee, K. H., Kim, J. H., Im, Y. H., Kim, J. Y., Kim, T. Y., Lee, K. H., Ahn, J. H., Kim, G. M., Park, I. H., Lee, S. J., Han, H. S., Kim, S. H. & Jung, K. H., Nov 2017, In : European Journal of Cancer. 86, p. 385-393 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Meeting highlights: The second consensus conference for breast cancer treatment in Korea

Lee, S., Park, I. H., Park, S., Sohn, J., Jeong, J., Ahn, S. G., Lee, I. J., Lee, H. K., Lee, S. A., Park, W., Lee, K. H., Kim, S. W., Han, S. A., Jung, K. H. & Son, B. H., Sep 2017, In : Journal of Breast Cancer. 20, 3, p. 228-233 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Antitumor effect of KX-01 through inhibiting Src family kinases and mitosis

Kim, S., Min, A., Lee, K. H., Yang, Y., Kim, T. Y., Lim, J. M., Park, S. J., Nam, H. J., Kim, J. E., Song, S. H., Han, S. W., Oh, D. Y., Kim, J. H., Kim, T. Y., Hangauer, D., Lau, J. Y. N., Im, K., Lee, D. S., Bang, Y. J. & Im, S. A., 1 Jul 2017, In : Cancer Research and Treatment. 49, 3, p. 643-655 13 p.

Research output: Contribution to journalArticle

4 Scopus citations

Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer

Lee, K. M., Jung, D. Y., Hwang, H., Kim, W. H., Lee, J. Y., Kim, T. Y., Im, S. A., Lee, K. H., Spiegel, D. & Hahm, B. J., 21 Apr 2017, In : Chronobiology International. 34, 4, p. 480-491 12 p.

Research output: Contribution to journalArticle

4 Scopus citations
2 Scopus citations

AZD6738, A novel oral inhibitor of ATR, induces synthetic lethality with ATM deficiency in gastric cancer cells

Min, A., Im, S. A., Jang, H., Kim, S., Lee, M., Kim, D. K., Yang, Y., Kim, H. J., Lee, K. H., Kim, J. W., Kim, T. Y., Oh, D. Y., Brown, J., Lau, A., O'Connor, M. J. & Bang, Y. J., Apr 2017, In : Molecular cancer therapeutics. 16, 4, p. 566-577 12 p.

Research output: Contribution to journalArticle

34 Scopus citations

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

Keam, B., Kim, M. K., Choi, Y., Choi, S. J., Choe, P. G., Lee, K. H., Kim, T. M., Kim, T. Y., Oh, D. Y., Kim, D. W., Im, S. A., Kim, N. J., Heo, D. S., Park, W. B. & Oh, M. D., 1 Mar 2017, In : Cancer. 123, 5, p. 841-848 8 p.

Research output: Contribution to journalArticle

11 Scopus citations
26 Scopus citations

Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

Kim, H. J., Min, A., Im, S. A., Jang, H., Lee, K. H., Lau, A., Lee, M., Kim, S., Yang, Y., Kim, J., Kim, T. Y., Oh, D. Y., Brown, J., O'Connor, M. J. & Bang, Y. J., 1 Jan 2017, In : International Journal of Cancer. 140, 1, p. 109-119 11 p.

Research output: Contribution to journalArticle

19 Scopus citations
6 Scopus citations

Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment

An, E., Ock, C. Y., Kim, T. Y., Lee, K. H., Han, S. W., Im, S. A., Kim, T. Y., Liao, W. L., Cecchi, F., Blackler, A., Thyparambil, S., H. Kim, W., Burrows, J., Hembrough, T., Catenacci, D. V. T., Oh, D. Y. & Bang, Y. J., 1 Jan 2017, In : Annals of Oncology. 28, 1, p. 110-115 6 p.

Research output: Contribution to journalArticle

12 Scopus citations

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

Ock, C. Y., Nam, A. R., Bang, J. H., Kim, T. Y., Lee, K. H., Han, S. W., Im, S. A., Kim, T. Y., Bang, Y. J. & Oh, D. Y., 1 Jan 2017, In : Gastric Cancer. 20, 1, p. 164-174 11 p.

Research output: Contribution to journalArticle

8 Scopus citations
6 Scopus citations
2016
12 Scopus citations

Longitudinal Association of Poor Sleep Quality with Chemotherapy-Induced Nausea and Vomiting in Patients with Breast Cancer

Jung, D., Lee, K. M., Kim, W. H., Lee, J. Y., Kim, T. Y., Im, S. A., Lee, K. H., Spiegel, D. & Hahm, B. J., 1 Oct 2016, In : Psychosomatic Medicine. 78, 8, p. 959-965 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer

Jin, M. S., Park, I., Kim, J. Y., Chung, Y. R., Im, S-A., Lee, K-H., Moon, H. G., Han, W., Noh, D. & Ryu, H. S., 1 Aug 2016, In : Tumor Biology. 37, 8, p. 11017-11024 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer

Jin, M. S., Lee, H., Park, I., Chung, Y. R., Im, S-A., Lee, K-H., Moon, H. G., Han, W., Kim, K., Kim, T-Y., Noh, D. & Ryu, H. S., 1 Aug 2016, In : Virchows Archiv. 469, 2, p. 183-190 8 p.

Research output: Contribution to journalArticle

17 Scopus citations

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

Cha, Y., Kim, K. J., Han, S-W., Rhee, Y. Y., Bae, J. M., Wen, X., Cho, N. Y., Lee, D. W., Lee, K-H., Kim, T-Y., Oh, D-Y., Im, S-A., Bang, Y. J., Jeong, S-Y., Park, K. J., Kang, G. & Kim, T., 12 Jul 2016, In : British Journal of Cancer. 115, 2, p. 164-171 8 p.

Research output: Contribution to journalArticle

24 Scopus citations

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: Real-world analysis of Korean national database

Shin, S., Park, C. M., Kwon, H. & Lee, K. H., 11 Jul 2016, In : BMC Cancer. 16, 1, 443.

Research output: Contribution to journalArticle

11 Scopus citations

A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors

Doi, T., Lee, K. H., Kim, T. M., Ohtsu, A., Kim, T. Y., Ikeda, M., Yoh, K., Gallo Stampino, C., Hirohashi, T., Suzuki, A., Fujii, Y., Andrew Williams, J. & Bang, Y. J., 1 Jul 2016, In : Cancer Medicine. 5, 7, p. 1454-1463 10 p.

Research output: Contribution to journalArticle

5 Scopus citations

Src as a Therapeutic Target in Biliary Tract Cancer

Nam, A. R., Kim, J. W., Park, J. E., Bang, J. H., Jin, M. H., Lee, K-H., Kim, T-Y., Han, S-W., Im, S-A., Kim, T., Oh, D-Y. & Bang, Y. J., Jul 2016, In : Molecular cancer therapeutics. 15, 7, p. 1515-1524 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Dermatomyositis in a patient with cholangiocarcinoma detected by an [18F]-fluorodeoxyglucose positron emission tomography-computed tomography scan

Suh, K. J., Park, J. K., Cho, S., Park, H., Baek, H. W., Lee, K., Lee, D. S. & Lee, K. H., 1 Apr 2016, In : Cancer Research and Treatment. 48, 2, p. 848-852 5 p.

Research output: Contribution to journalArticle

1 Scopus citations

Effect of time interval between breast-conserving surgery and radiation therapy on outcomes of node-positive breast cancer patients treated with adjuvant doxorubicin/cyclophosphamide followed by taxane

Koh, H. K., Shin, K. H., Kim, K., Lee, E. S., Park, I. H., Lee, K. S., Ro, J., Jung, S. Y., Lee, S., Kim, S. W., Kang, H. S., Chie, E. K., Han, W., Noh, D., Lee, K-H., Im, S-A. & Ha, S. W., 1 Apr 2016, In : Cancer Research and Treatment. 48, 2, p. 483-490 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

Ock, C. Y., Kim, T. Y., Lee, K. H., Han, S. W., Im, S. A., Kim, T. Y., Bang, Y. J. & Oh, D. Y., 1 Apr 2016, In : Gastric Cancer. 19, 2, p. 421-430 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer

Jin, M. S., Hyun, C. L., Park, I. A., Kim, J. Y., Chung, Y. R., Im, S. A., Lee, K. H., Moon, H. G. & Ryu, H. S., 1 Apr 2016, In : Tumor Biology. 37, 4, p. 4743-4753 11 p.

Research output: Contribution to journalArticle

16 Scopus citations
10 Scopus citations
3 Scopus citations
365 Scopus citations

Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer

Chung, S. Y., Jung, Y. Y., Park, I., Kim, H., Chung, Y. R., Kim, J. Y., Park, S. Y., Im, S-A., Lee, K-H., Moon, H. G., Noh, D., Han, W., Lee, C., Kim, T-Y. & Ryu, H. S., 1 Feb 2016, In : Clinical and Experimental Metastasis. 33, 2, p. 179-185 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
18 Scopus citations

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

Lee, E. S., Han, W., Kim, M. K., Kim, J., Yoo, T. K., Lee, M. H., Lee, K. H., Kim, T. Y., Moon, H. G., Im, S. A., Noh, D. Y. & Lee, E. S., 1 Jan 2016, In : BMC Cancer. 16, 1, 430.

Research output: Contribution to journalArticle

6 Scopus citations

Therapeutic implication of HER2 in advanced biliary tract cancer

Nam, A. R., Kim, J. W., Cha, Y., Ha, H., Park, J. E., Bang, J. H., Jin, M. H., Lee, K. H., Kim, T. Y., Han, S. W., Im, S. A., Kim, T. Y., Oh, D. Y. & Bang, Y. J., 1 Jan 2016, In : Oncotarget. 7, 36, p. 58007-58021 15 p.

Research output: Contribution to journalArticle

16 Scopus citations
2015

Clinical implication of anti-angiogenic effect of regorafenib in metastatic colorectal cancer

Lim, Y., Han, S. W., Yoon, J. H., Lee, J. M., Lee, J. M., Paeng, J. C., Won, J. K., Kan, G. H., Jeong, S. Y., Park, K. J., Lee, K. H., Kim, J. H. & Kim, T. Y., 1 Dec 2015, In : PLoS ONE. 10, 12, 0145004.

Research output: Contribution to journalArticle

16 Scopus citations

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

Lim, S. H., Kim, T. W., Hong, Y. S., Han, S. W., Lee, K-H., Kang, H. J., Hwang, I. G., Lee, J. Y., Kim, H. S., Kim, S. T., Lee, J., Park, J. O., Park, S. H., Park, Y. S., Lim, H. Y., Jung, S. H. & Kang, W. K., 17 Nov 2015, In : British Journal of Cancer. 113, 10, p. 1421-1426 6 p.

Research output: Contribution to journalArticle

28 Scopus citations
4 Scopus citations
94 Scopus citations

Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype

Chung, Y. R., Kim, H., Park, S. Y., Park, I., Jang, J. J., Choe, J. Y., Jung, Y. Y., Im, S-A., Moon, H. G., Lee, K-H., Suh, K. J., Kim, T-Y., Noh, D., Han, W. & Ryu, H. S., 1 Jul 2015, In : Human Pathology. 46, 7, p. 1027-1035 9 p.

Research output: Contribution to journalArticle

18 Scopus citations
26 Scopus citations
7 Scopus citations